Generex Biotechnology receives approval from the Ministry of Health of the United Arab Emirates to sell Generex Oral-lyn T

Imperial College London Diabetes Centre receives approval to sell to patients through the diabetes centre in Abu Dhabi, United Arab Emirates

13-Dec-2007

Generex Biotechnology Corporation announced that the Ministry of Health of the United Arab Emirates, Drugs Control Department has issued a non-objection letter to the Imperial College London diabetes Centre to import Generex Oral-lyn, Generex's proprietary oral insulin spray product, into Abu Dhabi. The Manager of the Drugs Control Department indicated that importation of Generex Oral-lyn can be done by via the issuance of a purchase order from the Imperial College London Diabetes Centre to a drug store or pharmacy licensed by the Ministry of Health of the United Arab Emirates.

The Imperial College London Diabetes Centre is a state-of-the-art specialized centre which is part of the government-supported Zayed Military Hospital. An estimated total of 5,000 patients are treated at the Imperial College London Diabetes Centre which is considered a leading diabetes resource in the region. Along with Generex's Middle Eastern distributor, Leosons General Trading Company, distributor of North American healthcare products in the region, a submission was prepared and filed with the Ministry of Health, UAE which resulted in the importation approval.

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances